about
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder de...
Read More
4.86
-0.02
(-0.41%)
10,857
XNAS Volume
XNAS 27 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Pulmatrix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..